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Abstract 
Background: Despite modern advances in intensive care medicine and surgical techniques, mortality rates in cardiac 
surgical patients are still about 3%. Considerable efforts were made to predict morbidity and mortality after cardiac 
surgery. In this study, we analysed the predictive properties of EuroScore and IL-6 for mortality in ICU, prolonged post-
operative mechanical ventilation, and prolonged stay in ICU.
Methods: We enrolled 2972 patients undergoing cardiac surgery. The patients either underwent aortic valve surgery 
(AV), mitral valve surgery (MV), coronary artery bypass grafting (CABG), and combined operations of aortic valve and 
coronary artery bypass grafting (AV + CABG) or of mitral and tricuspid valve (MV + TV). Different laboratory and clinical 
parameters were analysed.
Results: EuroScore as well as IL-6 were associated with increased mortality after cardiac surgery. Furthermore, a 
higher EuroScore and elevated levels of IL-6 were predictors for prolonged mechanical ventilation and a longer stay in 
ICU. Especially, highly significant elevated IL-6 levels and an increased EuroScore showed a strong association. Statis-
tics suggested superiority when both parameters were combined in a single model.
Conclusion: Our results suggest that EuroScore and IL-6 are helpful in predicting the course in ICU after cardiac 
surgery, and therefore, the use of intensive care resources. Especially, the combination of highly elevated levels of IL-6 
and EuroScore may prove to be excellent predictors for an unfortunate postoperative course in ICU.
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Introduction
Over the last decades, an astonishing progress was reg-
istered in cardiac surgery [1]. Operations of most com-
plex cardiovascular pathologies and abnormalities have 
become somehow routine nowadays [2]. Despite modern 
advances in intensive care medicine and surgical tech-
niques, mortality rates (within 30  days after surgery) in 
all cardiac surgical patients are still about 3% [3, 4].
Considerable efforts were made to predict postopera-
tive morbidity and mortality after cardiac surgery in the 
past [5–7]. Several studies attempted to find single pre-
dictors or developed algorithms and scoring systems to 
identify patient characteristics with an increased risk of 
an adverse outcome after surgery [8, 9]. One of the most 
established predictive models is the European System 
for Cardiac Operative Risk Evaluation (EuroScore) [9]. 
The EuroScore is a simple-to-use, objective, and well 
validated scoring system to predict early mortality after 
cardiac surgery [9]. Patient characteristics, as well as car-
diac and operation related risk variables are collected 
and weighted differently within this model [9]. It consid-
ers previous cardiac surgery, emergency surgery other 
than isolated coronary artery bypass grafting (CABG), 
and surgery on thoracic aorta [9]. The use of the Euro-
Score to predict mortality (30  days from operation or 
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well documented in the literature [10]. Its association 
with postoperative parameters is less well investigated. 
An association of the EuroScore and the length of stay in 
ICU after cardiac surgery was shown in a recent research 
conducted at a single centre in the UK [11]. The role of 
EuroScore to predict other postoperative parameters like 
length of mechanical ventilation seems to be unknown.
Recent research showed that systemic inflammation 
after cardiac surgery is associated with an increased mor-
tality [12]. While the EuroScore considers several impor-
tant clinical parameters, the inflammatory response 
after cardiac surgery is not included. The inflamma-
tory response in the setting of cardiac surgery can most 
likely be explained by surgical trauma, cardiopulmonary 
bypass, and reperfusion injury [13, 14]. Interleukin-6 
(IL-6) is induced by tumour necrosis factor (TNF)-α and 
reflects the localized TNF-α activity suggesting a major 
role of TNF-α and IL-6 in the inflammatory response 
after cardiac surgery [13, 14]. However, the association of 
IL-6 with short-term outcome after cardiac surgery has 
not been investigated yet.
Therefore, the aim of our study was to investigate the 
association and possible predictive properties of (i) the 
EuroScore and (ii) IL-6 serum levels for mortality in ICU, 
prolonged postoperative mechanical ventilation, and 
prolonged stay in ICU after cardiac surgery.
Material and methods
The study followed the principles of the Declaration of 
Helsinki and was approved by the Institutional Review 
Board of the Ludwig Maximilians University Munich 
(approval number: 748-15).
Patients
We retrospectively analysed the records of 2972 patients 
who underwent either CABG, aortic valve surgery (AV), 
combined operation of aortic valve and coronary artery 
bypass grafting (AV + CABG), mitral valve surgery (MV), 
and combined operation of mitral and tricuspid valve 
(MV + TV) at the University  of Munich (LMU;  Herzk-
linik der Universität München am Augustinum) over a 
period of 5 years. None of the patients had signs of infec-
tion in either clinical examination or laboratory testing.
Recorded parameters
The documented parameters analysed in this study were: 
age, sex, ejection fraction (EF) and serum creatinine level 
before operation, duration of cardiopulmonary bypass 
(CPB), length of stay in the ICU, length of mechanical 
ventilation, serum levels of interleukin 6 (IL-6) 6 h after 
operation, additive EuroScore (calculated during the pre-
operative assessment), and death after cardiac surgery.
ICU procedures
All operations were performed under extracorporeal cir-
culation. Clinical management (mechanical ventilation, 
extubation, fluid management, catecholamine support, 
and discharge from the ICU) was performed according to 
a standardized protocol. All patients were mechanically 
ventilated at admission to the ICU. Tracheal extubation 
was performed after a period of spontaneous breath-
ing according to the following criteria: absence of resid-
ual muscle paralysis, adequate ventilatory parameters, 
patient awake, and cooperative. Fluid therapy was guided 
by transoesophageal echocardiography and haemody-
namic monitoring. Normovolemia was achieved by infu-
sions of crystalloids and colloids.
Discharge from the ICU required the following criteria: 
hemodynamic stability without pharmacological support, 
adequate gas exchange, no signs of bleeding or systemic 
infections, and adequate urine output.
Statistical analyses
In a first step, we analysed different possible predictors 
for mortality in ICU after surgery. Investigated variables 
were the EuroScore and IL-6 serum levels. Furthermore, 
we included age (linear in years), sex, pre-operative 
serum creatinine levels, duration of cardiopulmonary 
bypass, EF, and kind of cardiac surgery. For this, we fitted 
univariable logistic regression models with death as out-
come variable. In a second step, we investigated different 
possible predictors for (a) duration of ventilation after 
surgery and (b) duration of stay in ICU after surgery. We 
included the same exposure variables as listed above. 
We fitted univariable and multivariable logistic regres-
sion models. In multivariable models we further tested 
for interactions between EuroScore and IL-6 serum lev-
els and the other included variables using likelihood ratio 
tests. As the EuroScore could not be obtained in a small 
number of patients, we performed sensitivity analyses, 
repeating analyses for the other variables in patients (a) 
where the Euroscore was obtained and (b) without Euro-
Score. Variables with a p value ≤ 0.05 (likelihood ratio 
test) were considered as statistically significant. Multi-
variable models were compared with the likelihood ratio 
test. All statistical analyses were performed using Stata™ 




We analysed data from 2972 patients (2105 male, approx-
imately 71%) undergoing cardiac surgery. Of those, 1568 
patients underwent CABG, 729 AV, 359 AV + CABG, 
262 MV, and 54 MV + TV, respectively. After surgery, 
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patients were transferred to ICU. The median interquar-
tile range (IQR) stay in ICU for all patients was 2 (1–4) 
days and the median (IQR) of mechanical ventilation was 
12 (8–18) hours after surgery. Amongst 2972 patients, 
40 (1.3%) died in ICU after surgery. The 30-day mortal-
ity was 1.6% (49 patients), the 90-day mortality was 1.9% 
(56 patients). Spearmen correlation did not show a sig-
nificant correlation between age and IL-6 levels 6 h after 
surgery (r = 0.005; p = 0.776). For details, see Table 1.
Possible predictors for mortality in ICU after cardiac 
surgery
We investigated the association of the EuroScore and 
IL-6 serum levels with other possible predictors for mor-
tality in ICU after cardiac surgery. In the univariable 
models, a higher EuroScore and higher IL-6 levels were 
associated with mortality in ICU after surgery. For IL-6, 
only the highest quintile (> 421  pg/ml) reached the sig-
nificance level. In addition, older age, elevated pre-oper-
ative serum creatinine, longer CPB time and lower EF, as 
well as kind of surgery (with a lower risk for CABG and 
AV and the highest risk after MV and TV replacement) 
were associated with mortality in ICU after surgery. The 
results are summarized in more detail in Table 2.
Possible predictors for prolonged mechanical ventilation 
and length of stay in ICU after cardiac surgery
In an additional analysis, we investigated the known 
risk factors from the primary analysis (above) and chose 
as outcome parameters (a) duration of ventilation (in 
hours, dividing the patients into two sub-groups, less or 
more than 12 h) and (b) duration of treatment in ICU (in 
days, again dividing the patients into 2 sub-groups, less 
or more than 2  days). In univariable analyses, we could 
confirm that both outcome parameters, the EuroScore 
and IL-6 serum levels as well as the other predictors for 
Table 1 Characteristics of the study population
Results are displayed in numbers (%) if not stated otherwise. aResults are 
displayed as median (IQR)
ICU intensive care unit, EF ejection fraction, CPB cardiopulmonary bypass, CABG 
coronary artery bypass grafting, AV aortic valve surgery, CABG + AV combined 
operation of aortic valve and coronary artery bypass grafting, MV mitral valve 
surgery, MV + TV combined operation of mitral and tricuspid valve
Patients (n = 2972)
Anthropometrics
 Sex, males 2105 (70.8)
 Age  [years]a 72 (64–78)
 Death after surgery [n] 40 (1.3)
Intensive care treatment
 Duration of ventilation  [hours]a 12 (8–18)
 Length of stay in ICU  [days]a 2 (1–4)
EuroScore
 Low risk (0–2) 800 (27.4)
 Medium risk (3–5) 1176 (39.6)
 High risk (> 6) 871 (29.3)
Laboratory  assessmenta
 IL-6 [pg/ml] 206 (116–364)
 Creatinine [mg/dl] 1 (0.9–1.2)
EF [%]a 65 (55–65)
CPB  [min]a 92 (75–117)
Surgery
 CABG 1568 (52.8)
 AV 729 (24.5)
 CABG + AV 359 (12.1)
 MV 262 (8.8)
 MV + TV 54 (1.8)
Table 2 Investigation of possible predictors for mortality after 
cardiac surgery
Logistic regression model investigating possible predictors for death (yes/no) 
after cardiac surgery. Only results from the univariable models are displayed
EF ejection fraction, CPB cardiopulmonary bypass, OR odds ratio, CI confidence 
interval
a Age is analysed as linear variable
b The reference category are male
c EF displayed in quintiles (resulting in 3 groups), reference category are values 
45
d EuroScore is analysed in three groups according to guidelines: mild/moderate/
severe risk. The reference category is the lowest score
e Creatinine is displayed in three groups. The reference category are lowest 
values
f IL-6 is displayed in quintiles. The reference category is the first quintile
g CPB. Due to the low (missing) number of deaths in the lower quintiles, overall 
OR is displayed
h p value: from likelihood ratio test
Variable Category OR 95% CI p valueh
Agea Linear 1.08 [1.03, 1.12] 0.001
Sexb Male 1 [1.00, 1.00] 0.03
Female 1.46 [0.77, 2.79]
EF [%]c 25–45 1 [1.00, 1.00] 0.0003
46–64 0.19 [0.07, 0.57]
65 0.3 [0.16, 0.58]
EuroScored 0–2 1 [1.00, 1.00]  < 0.001
3–5 2.05 [0.41, 10.17]
 > 6 13.25 [3.15, 55.81]
Creatinine [mg/dl]e  < 1.2 1 [1.00, 1.00]  < 0.001
1.2–2.1 5.6 [2.67, 11.76]
 > 2.1 13.09 [4.66, 36.81]
IL-6 [pg/ml]f Q1 (< 102) 1 [1.00, 1.00]  < 0.001
Q2 (102–165) 1.51 [0.25, 9.09]
Q3 (166–256) 2.01 [0.37, 11.02]
Q4 (257–421) 2.03 [0.37, 11.11]
Q5 (> 421) 12.6 [2.96, 53.55]
CPB  [min]g 2.3 1.66, 3.15  < 0.001
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mortality in ICU after surgery (Table  2) were associ-
ated with the duration of ventilation and the length of 
stay in ICU (Tables  3, 4, respectively). IL-6 measures 
did not reach significance level in the univariable model 
for duration of stay in ICU, however, confidence inter-
vals showed a difference for the sub-group with highest 
IL-6 levels. To identify possible confounding factors, we 
then included all selected parameters in a multivariable 
model. Results of all selected parameters except sex were 
consistent with the univariable analyses, thus suggesting 
that all these parameters are associated with duration of 
ventilation and length of stay in ICU. The type of surgery 
was not associated with the time of ventilation in this 
setting. Taking a closer look at IL-6 measures, associa-
tion strengthened further in the multivariable analyses, 
with strong association observed not only in the highest 
Table 3 Investigation of possible predictors for duration of ventilation after cardiac surgery
Logistic regression model investigating possible predictors for duration of ventilation after cardiac surgery. Baseline are patients with a ventilation time ≤ 12 h. The 
univariable model are shown in the left columns, the multivariable model adjusted to all variables listed above is presented in the right columns
a Age is analysed as linear variable
b The reference category are males
c Ejection fraction (EF) displayed in quintiles (resulting in 3 groups), reference category are values ≤ 45
d EuroScore analysed in three groups according to guidelines: mild/moderate/severe risk. The reference category is the lowest score
e Creatinine displayed in three groups. The reference category are lowest values
f IL-6 is displayed in Q (quintiles). The reference category is the first quintile
g CPB is displayed in Q (quintiles). The reference category is the first quintile
h Reference category is CABG
j p value: from likelihood ratio test
OR odds ratio, CI confidence interval, EF ejection fraction, CPB cardiopulmonary bypass, CABG coronary artery bypass grafting, AV aortic valve surgery, CABG + AV 
combined operation of aortic valve and coronary artery bypass grafting, MV mitral valve surgery, MV + TV combined operation of mitral and tricuspid valve
Variable Category Univariable model Multivariable model
OR 95% CI p  valuej OR 95% CI p  valuej
Age  [years]a Linear 1.03 [1.02, 1.04]  < 0.001 1.01 [1.00, 1.02] 0.004
Sexb Male 1 [1.00, 1.00] 0.066 1 [1.00, 1.00] 0.15
Female 1.16 [0.99, 1.36] 1.15 [0.95, 1.38]
EF [%]c  ≤ 45 1 [1.00, 1.00] 0.015 1 [1.00, 1.00] 0.004
46–64 0.76 [0.61, 0.95] 1.02 [0.80, 1.29]
 ≥ 65 0.59 [0.49, 0.71] 0.77 [0.62, 0.95]
EuroScored 0–2 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00]  < 0.001
3–5 1.56 [1.29, 1.88] 1.29 [1.03, 1.62]
 > 6 3.05 [2.50, 3.74] 2.07 [1.58, 2.72]
Creatinine [mg/dl]e  < 1.2 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00]  < 0.001
1.2–2.1 1.73 [1.48, 2.04] 1.54 [1.29, 1.83]
 > 2.1 2.99 [1.93, 4.63] 1.9 [1.18, 3.05]
IL-6 [pg/ml]f Q1 (< 102) 1 [1.00, 1.00] 0.009 1 [1.00, 1.00] 0.003
Q2 (102–165) 1.01 [0.80, 1.427] 1.16 [0.91, 1.49]
Q3 (166–256) 1.16 [0.92, 1.46] 1.35 [1.05, 1.73]
Q4 (257–421) 1.11 [0.88, 1.40] 1.39 [1.07, 1.80]
Q5 (> 421) 1.45 [1.16, 1.83] 1.79 [1.38, 2.32]
CPB  [min]g Q1 (< 72) 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00]  < 0.001
Q2 (72–85) 1 [0.80, 1.27] 0.97 [0.76, 1.24]
Q3 (86–100) 1.04 [0.82, 1.31] 0.97 [0.75, 1.24]
Q4 (101–124) 1.16 [0.92, 1.46] 1.09 [0.85, 1.40]
Q5 (> 124) 1.83 [1.45, 2.30] 1.66 [1.27, 2.16]
Operationh CABG 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00] 0.53
AV 0.99 [0.83, 1.018] 1.01 [0.83, 1.24]
CABG + AV 1.43 [1.13, 1.80] 1.08 [0.82, 1.43]
MV 1.13 [0.87, 1.47] 1.08 [0.80, 1.45]
MV + TV 3.26 [1.78, 5.97] 1.78 [0.91, 3.51]
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quintile of IL-6 levels, but already in the lower quantiles 
(Tables 3, 4, respectively). We observed that the duration 
of mechanical ventilation and length of stay increased 
in patients with a combination of higher EuroScore and 
higher IL-6 measures, than elevated EuroScore and IL-6 
measures alone (regression model including interac-
tion terms, likelihood ratio test: p = 0.01 and p = 0.003, 
respectively, details are provided in Additional file  1: 
Table  S1 and Additional file  2: Table  S2). As the Euro-
Score could not be obtained in 125 patients, we per-
formed sensitivity analyses for the other variables in 
patients (a) with EuroScore and (b) without EuroScore. 
After adjustment for confounders, results remained 
robust in all analyses, indicating that the EuroScore and 
IL-6 measures alone and combined, were excellent pre-
dictors for all investigated outcomes.
Table 4 Investigation of possible predictors for duration of stay in ICU after surgery
Logistic regression model investigating possible predictors for duration of stay in ICU. Baseline are patients being dismissed from ICU ≤ 2 days (compared to patients 
with being hospitalized on ICU > 2 days). The univariable model is shown on the left, the multivariable model on the right
a Age is analysed as linear variable
b The reference category are males
c Ejection fraction (EF) displayed in quintiles (resulting in 3 groups), reference category are values ≤ 45
d EuroScore analysed in three groups according to guidelines: mild/moderate/severe risk. The reference category is the lowest score
e Creatinine displayed in three groups. The reference category are lowest values
f IL-6 is displayed in Q (quintiles). The reference category is the first quintile
g CPB is displayed in Q (quintiles). The reference category is the first quintile
h Reference category is CABG
j p value: from likelihood ratio test
OR odds ratio, CI confidence interval, EF ejection fraction, CPB cardiopulmonary bypass, CABG coronary artery bypass grafting, AV aortic valve surgery, CABG + AV 
combined operation of aortic valve and coronary artery bypass grafting, MV mitral valve surgery, MV + TV combined operation of mitral and tricuspid valve
Variable Category Univariable model Multivariable model
OR 95% CI p  valuej OR 95% CI p  valuej
Age  [years]a Linear 1.02 [1.01, 1.03]  < 0.001 1.01 [1.00, 1.02] 0.02
Sexb Male 1 [1.00, 1.00] 0.6 1 [1.00, 1.00] 0.8
Female 1.04 [0.89, 1.22] 1.03 [0.85, 1.24]
EF [%]c  ≤ 45 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00] 0.001
46–64 0.56 [0.45, 0.70] 0.71 [0.56, 0.90]
 ≥ 65 0.53 [0.44, 0.63] 0.68 [0.56, 0.84]
EuroScored 0–2 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00]  < 0.001
3–5 1.37 [1.14, 1.66] 1.29 [1.03, 1.61]
 > 6 2.61 [2.14, 3.18] 1.97 [1.50, 2.59]
Creatinine [mg/dl]e  < 1.2 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00]  < 0.001
1.2–2.1 1.76 [1.50, 2.07] 1.56 [1.31, 1.86]
 > 2.1 2.5 [1.64, 3.80] 1.71 [1.07, 2.72]
IL-6 [pg/ml]f Q1 (< 102) 1 [1.00, 1.00] 0.2 1 [1.00, 1.00] 0.009
Q2 (102–165) 1.18 [0.94, 1.48] 1.41 [1.10, 1.81]
Q3 (166–256) 1.17 [0.93, 1.47] 1.3 [1.01, 1.67]
Q4 (257–421) 1.12 [0.89, 1.41] 1.31 [1.01, 1.70]
Q5 (> 421) 1.33 [1.05, 1.67] 1.6 [1.23, 2.07]
CPB  [min]g Q1 (< 72) 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00]  < 0.001
Q2 (72–85) 1.18 [0.93, 1.48] 1.15 [0.90, 1.47]
Q3 (86–100) 0.99 [0.78, 1.25] 0.9 [0.70, 1.16]
Q4 (101–124) 1.2 [0.95, 1.51] 1.04 [0.81, 1.33]
Q5 (> 124) 2.29 [1.82, 2.89] 1.92 [1.47, 2.50]
Operationh CABG 1 [1.00, 1.00]  < 0.001 1 [1.00, 1.00] 0.02
AV 0.84 [0.70, 1.00] 0.89 [0.73, 1.08]
CABG + AV 1.17 [0.93, 1.47] 0.89 [0.67, 1.17]
MV 1.29 [0.99, 1.67] 1.28 [0.95, 1.72]
MV + TV 3.67 [1.98, 6.81] 2.19 [1.09, 4.36]
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Discussion
Prediction of morbidity and mortality after cardiac sur-
gery during the stay in ICU is a very important issue for 
the patients, for the management of an ICU, and for the 
relatives of the patients. Furthermore, predictors should 
also be able to guide clinicians in making recommenda-
tions about an operation by helping them to weigh the 
risks against the benefits. These predictors may also serve 
as an instrument of quality control. In our study, the 
EuroScore as well as IL-6 measures were associated with 
an increased mortality after cardiac surgery. Further-
more, a higher EuroScore (calculated before operation) 
and significant elevated IL-6 levels (measured 6  h after 
operation) were predictors for prolonged mechanical 
ventilation and a longer stay in ICU.
In his work, Meadows et al. [11] showed the predictive 
value of the EuroScore in terms of length of stay in ICU. 
Since this evaluation has been performed in a single cen-
tre in the UK, these findings cannot be generally applied 
to patients outside the UK without further investigation. 
However, observations made by Meadows et al. [11] are 
consistent with the findings in our trial conducted with 
a large sample size of 2972 patients residing in Germany. 
While Meadows et al. [11] analysed the value of the Euro-
Score in predicting the length of stay in ICU after cardiac 
surgery, our analyses could also show the potential of the 
EuroScore in predicting the length of mechanical venti-
lation. This is a very important finding especially when 
there are limited resources for mechanical ventilation. 
During the COVID-19 pandemic, when many hospitals 
faced a severe shortage of resources for the mechanical 
ventilation [15], an instrument that helps to manage the 
usage of respirators is extremely valuable.
Another interesting and surprising finding of our anal-
yses was that the variable, gender (female) is associated 
with an increased mortality without being associated 
with prolonged mechanical ventilation. The findings in 
our study support a well-known phenomenon in cardiac 
surgery, namely that women have higher morbidity and 
mortality after cardiac surgery than men. Different expla-
nations for this phenomenon have been suggested. This 
includes anatomically smaller coronary arteries in the 
female heart, the older age of women undergoing car-
diac surgery, a higher likelihood of unstable angina and 
higher rates of comorbidities in women [16, 17]. In gen-
eral, scientific data supporting these explanations are still 
rare. One possible approach is seen in a higher risk for 
new neurological events after cardiac surgery as a cause 
for increased 30-day mortality in women undergoing 
cardiac surgery [18]. The scientific discussion related to 
the influence of female gender on prolonged mechani-
cal ventilation after surgery is controversial [19]. Some 
work favours female gender as a risk factor in these 
circumstances, other suggest no influence of the female 
gender on prolonged mechanical ventilation [19]. In our 
study, female gender was not a predictor for the length of 
mechanical ventilation. To address this question in more 
detail, further research has to be performed with this 
specific scientific question.
Several risk models have been developed to predict 
mortality after cardiac surgery [20]. One of the best-
known risk models for patients undergoing cardiac sur-
gery is the EuroScore [9]. The EuroScore was initially 
developed to predict the peri-operative mortality in 
patients undergoing CABG [9]. It is known that different 
versions of the EuroScore exist, an additive and a logis-
tic version. The additive version is easier and more prac-
tical to use than the logistic form [21]. There is still an 
ongoing controversy concerning the possible advantages 
of one model over the other [21]. Depending on the ana-
lysed patient group and the scientific issue, researchers 
found no advantage of using the logistic over the addi-
tive model [22], others found advantages of the logistic 
model in high-risk patients [23]. However, the additive 
EuroScore has been validated as predictor for the postop-
erative course after cardiac surgery [11, 24–26]. Since it is 
more convenient to use, the additive EuroScore, we used 
this version in our study. We could show that the additive 
EuroScore is also a good predictor for the length of stay 
in ICU and for the duration of mechanical ventilation.
Off-pump cardiac procedures are associated with 
decrease in inflammatory response and postoperative 
morbidity, however, CPB is still inevitable in a large num-
ber of surgical procedures [27, 28]. Notwithstanding the 
tireless development and improvement of CPB, CPB still 
leads to activation of the coagulation, fibrinolytic, and 
inflammatory system [29–31]. These pathophysiological 
changes are most reasonably caused by the exposition 
of the blood to the artificial surface of the bypass circuit 
[32]. The consequence is frequently a degranulation of 
leukocytes and a release of cytotoxic and inflammatory 
mediators such as interleukins [29–31]. Lymphocytes, 
fibroblasts, macrophages, and endothelial cells are the 
main source for secretion of IL-6 in humans [33]. IL-6 
itself is an important proinflammatory mediator well 
characterized in the orchestration of the inflammatory 
processes [34]. It has been suggested that the myocar-
dium produces IL-6 during phases of compromised myo-
cardial function as a result of ischemia and reperfusion 
injuries [35]. Furthermore, the surgical trauma might 
also be reasonable for an increase of IL-6 within the first 
4 to 6 h after surgery [35, 36]. These close interlockings 
of IL-6, surgical trauma and myocardial function makes 
IL-6 an interesting parameter for predicting the outcome 
of cardiac surgery in ICU. Indeed, our analyses showed 
that especially IL-6 serum levels 6 h after operation could 
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be a useful predictor for mortality, prolonged mechani-
cal ventilation, and prolonged stay in ICU after cardiac 
surgery. IL-6 measures therefore might be a helpful 
parameter to optimize the management of postoperative 
processes and planning in ICU. Interestingly, the com-
bination of IL-6 and EuroScore might even improve the 
prediction of death, prolonged mechanical ventilation, 
and prolonged stay in ICU after cardiac surgery. There-
fore, one should consider including the inflammatory 
response after operations (e.g., IL-6 6 h after operations) 
when revising the EuroScore.
Strength and limitations
Strength of our study is the large dataset of patients and 
the large number of various patient-related variables that 
could be included. Furthermore, we could show for the 
first time the important role of IL-6 in predicting the out-
come during intensive care treatment.
The retrospective study design might be a limitation. 
Even if our patients are treated by standard operating 
procedures, we cannot rule out that some results have 
been influenced by modified treatment due to peri-oper-
ative complications. Furthermore, the study refers to a 
single centre regional database, thus our results need to 
be further evaluated in other institutions and countries. 
It has been shown that both additive and logistic Euro-
Score were predictive for the outcome after cardiac sur-
gery [37]. For our study, we used the additive EuroScore 
since it is very easy to use in clinical practice. Thus, we 
cannot rule out that the use of the logistic EuroScore may 
lead to different results. A significant correlation of NT-
BNP and the EuroScore has been shown in the past [38]. 
To minimize any interferences in our statistical model, 
we decided not to include this parameter in our analy-
ses. It might be possible that analysing cardiac-related 
biomarkers as NT-BNP or troponin might be also useful 
to predict the course in ICU. Finally, we focused on the 
evaluation of IL-6 as an inflammatory marker, therefore 
we cannot rule out that analysing other inflammatory 
markers (e.g., C-reactive protein, procalcitonin or white 
blood cell count) may lead to different results.
Conclusion and outlook
Especially in the context of the COVID-19-pandemia 
but already before, allocation of ICU capacities and effi-
cient resource allocation are important topics not just 
limited to cardiac surgery. Therefore, both pre-operative 
risk evaluation and postoperative outcome estimation are 
important aspects not only in the background of cata-
strophic situations, but also in regular major surgery set-
tings. The results of our study support the eligibility of an 
existing Score (EuroScore) and the utilization of an easy 
to measure parameter (IL-6) for prediction of the course 
of cardiac surgery thus supporting the clinical aspects 
and resource discussions. In the context of newly devel-
oped scoring systems for this specific purpose, our data 
should be considered in the future advancements of these 
scoring systems to support clinical decision-making, allo-
cation of resources and improvement of care for high-
risk patients before and during intensive care treatment.
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